Nasal administration of benzodiazepine hypnotics
USRE36744E · kind E · reissue
64Cited by
13References
25Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 16, 1994 |
| Grant date | Jun 20, 2000 |
| Priority date | — |
| Expiry date | Mar 16, 2014 |
Classification
- Technology area (CPC —)General
Abstract
Nasal administration of benzodiazepines is described as providing improved therapeutic effects as compared to conventional delivery techniques. The compositions comprise a benzodiazepine hypnotic in a pharmaceutically acceptable nasal carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.